Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.

Ferrández O, Urbina O, Grau S.

Drug Des Devel Ther. 2016 Dec 22;11:65-82. doi: 10.2147/DDDT.S84667. eCollection 2017. Review.

2.

Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe.

Nathwani D, Dryden M, Garau J.

Int J Antimicrob Agents. 2016 Aug;48(2):127-36. doi: 10.1016/j.ijantimicag.2016.04.023. Epub 2016 May 25. Review.

3.

Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.

Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, Petrosillo N, Tumbarello M, Venditti M, Viale P, Viscoli C, Bassetti M.

Clin Microbiol Infect. 2016 Apr;22 Suppl 2:S27-36. doi: 10.1016/S1198-743X(16)30095-7. Review.

4.

New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.

Crotty MP, Krekel T, Burnham CA, Ritchie DJ.

J Clin Microbiol. 2016 Sep;54(9):2225-32. doi: 10.1128/JCM.03395-15. Epub 2016 Mar 9. Review.

5.

Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia.

Montravers P, Harpan A, Guivarch E.

Adv Ther. 2016 Feb;33(2):151-66. doi: 10.1007/s12325-016-0293-x. Epub 2016 Feb 9. Review.

6.

New antibiotics in the management of acute bacterial skin and skin structure infections.

Gleghorn K, Grimshaw E, Kelly EK.

Skin Therapy Lett. 2015 Sep-Oct;20(5):7-9. Review.

7.

Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.

O'Driscoll T, Crank CW.

Infect Drug Resist. 2015 Jul 24;8:217-30. doi: 10.2147/IDR.S54125. eCollection 2015. Review.

8.

New developments in the management of severe skin and deep skin structure infections - focus on tedizolid.

Durkin MJ, Corey GR.

Ther Clin Risk Manag. 2015 May 22;11:857-62. doi: 10.2147/TCRM.S64553. eCollection 2015. Review.

9.

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections.

Hall RG 2nd, Michaels HN.

Infect Drug Resist. 2015 Apr 22;8:75-82. doi: 10.2147/IDR.S56691. eCollection 2015. Review.

10.

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.

Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S.

Drug Des Devel Ther. 2013 Apr 3;7:243-65. doi: 10.2147/DDDT.S30728. Print 2013. Review.

Supplemental Content

Loading ...
Support Center